Explore the vast range of titles available.

Primary retroperitoneal liposarcoma (PRPLS) is a rare malignant tumor with a low incidence. A 34-year-old female patient presented to our department with abdominal pain, nausea, and vomiting for 2 days. Abdominal computed tomography (CT) indicated a huge mass between the liver and kidney, with a clear boundary and measuring approximately 202 mm × 155 mm ×106 mm. The mass was considered a retroperitoneal lipoma or liposarcoma. The entire tumor was completely resected without auxiliary injury, and histopathology of the resected specimen indicated liposarcoma. The patient recovered well and was discharged from our department on the 6th postoperative day. No signs of relapse were seen during 1-year of follow-up. PRPLS is rare and without obvious symptoms in the early stage. CT plays a vital role in the diagnosis of PRPLS, and surgical resection is considered the most suitable treatment. Radiotherapy and chemotherapy might also be treatment options to improve the overall survival of PRPLS patients.

Sphingosine-1-phosphate (S1P), a pleiotropic lipid mediator, participates in various cellular processes during tumorigenesis, including cell proliferation, survival, drug resistance, metastasis, and angiogenesis. S1P is formed by two sphingosine kinases (SphKs), SphK1 and SphK2. The intracellularly produced S1P is delivered to the extracellular space by ATP-binding cassette (ABC) transporters and spinster homolog 2 (SPNS2), where it binds to five transmembrane G protein-coupled receptors to mediate its oncogenic functions (S1PR1-S1PR5). MicroRNAs (miRNAs) are small non-coding RNAs, 21–25 nucleotides in length, that play numerous crucial roles in cancer, such as tumor initiation, progression, apoptosis, metastasis, and angiogenesis via binding to the 3′‐untranslated region (3′‐UTR) of the target mRNA. There is growing evidence that various miRNAs modulate tumorigenesis by regulating the expression of SphKs, and S1P receptors. We have reviewed various roles of miRNAs, SphKs, S1P, and S1P receptors (S1PRs) in malignancies and how notable miRNAs like miR-101, miR-125b, miR-128, and miR-506, miR-1246, miR-21, miR-126, miR499a, miR20a-5p, miR-140-5p, miR-224, miR-137, miR-183-5p, miR-194, miR181b, miR136, and miR-675-3p, modulate S1P signaling. These tumorigenesis modulating miRNAs are involved in different cancers including breast, gastric, hepatocellular carcinoma, prostate, colorectal, cervical, ovarian, and lung cancer via cell proliferation, invasion, angiogenesis, apoptosis, metastasis, immune evasion, chemoresistance, and chemosensitivity. Therefore, understanding the interaction of SphKs, S1P, and S1P receptors with miRNAs in human malignancies will lead to better insights for miRNA-based cancer therapy.

Colorectal cancer (CRC) is a common clinical disease with a poor prognosis and a high recurrence rate. Chemotherapy is important to inhibit the post-surgical recurrence of CRC patients. But many limitations restrict the further application of chemotherapy. In this study, sorafenib (Sor) and metformin (Met) co-loaded poly(ethylene glycol)-block-poly(L-glutamic acid- co -L-phenylalanine) [mPEG- b -P(Glu- co -Phe)] micelles were developed. The characterizations, drug release, in vivo biodistribution, and pharmacokinetics of the micelles were analyzed. The treatment efficacy of the dual-drug loaded micelles was evaluated in a subcutaneous colon cancer mice model. Sor is a common molecular target agent that can inhibit the mitogen-activated protein kinase (MAPK) pathway to treat solid tumors. Met can also regulate the MAPK pathway and inhibit the expression of the phosphorylated extracellular signal-regulated kinase (p-ERK). Moreover, both Sor and Met play important roles in cell cycle arrest. The integration of these two drugs aims to achieve synergistic effects against colon cancer. The micelles can be targeted to cancer cells and possess longer blood circulation time. The two agents can be released rapidly in the tumor sites. The in vivo study showed that the micelles can prevent tumor progression by inhibiting the expressions of p-ERK and cyclin D1. This study indicated that the Sor/Met-loaded micelles are suitable for CRC treatment.

This study aimed to evaluate the effect of irreversible electroporation (IRE) on the stomach wall after IRE was applied on liver tissues adjacent to the anterior wall of the stomach. IRE ablation was performed in eight Tibet mini-pigs with three lesions per pig. The IRE electrodes were inserted into the liver tissues situated close to the anterior wall of the stomach. As for the control group, the IRE electrodes were also inserted into the liver tissues for three lesions in four Tibet mini-pigs but did not turn on the current. Serum aminotransferase and WBC levels clearly increased in all the IRE ablated animals by Day 1 and decreased gradually thereafter. The gross postmortem examination at 7 days post-IRE revealed a whitish lesion with sharp demarcation on the serosal surface of the stomach, but we could not find any signs of ablation or just find a small, slightly reddish lesion at the Day-28 examination. On the Day-7 histopathological examination, inflammation and fibrosis were observed in the serosal layer of the stomach in each animal and mild inflammation of the myofibers was found in only two pigs. All the stomach layers returned to normalcy by 28 days post-IRE. Thus, IRE ablation of hepatic tissues situated close to the stomach wall cannot lead to stomach perforation. IRE is therefore a safe procedure for ablating hepatic tumors that are adjacent to the stomach.

To improve synergistic anticancer efficacy and minimize the adverse effects of chemotherapeutic drugs, temozolomide (TMZ) and curcumin (CUR) co-loaded nanostructured lipid carriers (NLCs) were prepared by microemulsion in this study. And the physicochemical properties, drug release behavior, intracellular uptake efficiency, in vitro and in vivo anticancer effects of TMZ/CUR-NLCs were evaluated. TMZ/CUR-NLCs showed enhanced inhibitory effects on glioma cells compared to single drug loaded NLCs, which may be owing to that the quickly released CUR can sensitize the cancer cells to TMZ. The inhibitory mechanism is a combination of S phase cell cycle arrest associated with induced apoptosis. Notably, TMZ/CUR-NLCs can accumulate at brain and tumor sites effectively and perform a significant synergistic anticancer effect in vivo. More importantly, the toxic effects of TMZ/CUR-NLCs on major organs and normal cells at the same therapeutic dosage were not observed. In conclusion, NLCs are promising nanocarriers for delivering dual chemotherapeutic drugs sequentially, showing potentials in the synergistic treatment of tumors while reducing adverse effects both in vitro and in vivo.

Non-flow aqueous zinc-bromine batteries without auxiliary components (e.g., pumps, pipes, storage tanks) and ion-selective membranes represent a cost-effective and promising technology for large-scale energy storage. Unfortunately, they generally suffer from serious diffusion and shuttle of polybromide (Br−, Br3−) due to the weak physical adsorption between soluble polybromide and host carbon materials, which results in low energy efficiency and poor cycling stability. Here, we develop a novel self-capture organic bromine material (1,1′-bis [3-(trimethylammonio)propyl]-4,4′-bipyridinium bromine, NVBr4) to successfully realize reversible solid complexation of bromide components for stable non-flow zinc-bromine battery applications. The quaternary ammonium groups (NV4+ ions) can effectively capture the soluble polybromide species based on strong chemical interaction and realize reversible solid complexation confined within the porous electrodes, which transforms the conventional “liquid–liquid” conversion of soluble bromide components into “liquid–solid” model and effectively suppresses the shuttle effect. Thereby, the developed non-flow zinc-bromide battery provides an outstanding voltage platform at 1.7 V with a notable specific capacity of 325 mAh g−1NVBr4 (1 A g−1), excellent rate capability (200 mAh g−1NVBr4 at 20 A g−1), outstanding energy density of 469.6 Wh kg−1 and super-stable cycle life (20,000 cycles with 100% Coulombic efficiency), which outperforms most of reported zinc-halogen batteries. Further mechanism analysis and DFT calculations demonstrate that the chemical interaction of quaternary ammonium groups and bromide species is the main reason for suppressing the shuttle effect. The developed strategy can be extended to other halogen batteries to obtain stable charge storage. An ultra-stable non-flow zinc-bromine battery with a novel self-capture NVBr4 based cathode was developed. With the “self-capture” effect of the quaternary ammonium group, it can effectively capture the soluble bromine substances and realize reversible solid complexation, which transforms the conventional “liquid-liquid” conversion of soluble bromide components into “liquid-solid” model and effectively suppresses the shuttle effect. As a result, a notable specific capacity (325 mAh g−1NVBr4) and super-long cycling life up to 20000 cycles were realized. [Display omitted] •A self-capture organic bromine material (NVBr4) was developed for stable non-flow Zn/Br batteries.•The quaternary ammonium groups on NVBr4 can effectively capture the soluble bromine species.•The developed zinc-bromine batteries exhibit a notable specific capacity of 325 mAh g−1 at 1 A g−1.•The developed zinc-bromine batteries exhibit a super-long cycle life of 20000 cycles.•Mechanism study reveals that the strong chemical interaction effectively suppress the shuttle and dissolution issues.

Flexible aqueous zinc batteries (FAZBs) with high safety and environmental friendliness are promising smart power sources for smart wearable electronics. However, the bare zinc anode usually suffers from damnable dendrite growth and rampant side reaction on the surface, greatly impeding practical applications in FAZBs. Herein, a composite polymer interface layer is artificially self‐assembled on the surface of the zinc anode by graft‐modified fluorinated monomer (polyacrylic acid‐2‐(Trifluoromethyl)propenoic acid, PAA‐TFPA), on which an organic–inorganic hybrid (PAA‐Zn/ZnF2) solid electrolyte interface (SEI) with excellent ionic conductivity is formed by interacting with Zn2+. Both the pouch cell and fiber zinc anode exhibit excellent plating/stripping reversibility after protecting by this organic–inorganic SEI, which can be stably cycled more than 3000 h in symmetric Zn||Zn cells or 550 h in fiber Zn||Zn cells. Additionally, this interface layer preserves zinc anode with excellent mechanical durability under various mechanical deformation (stably working for another 1200 h after bending 100 h). The corresponding PAA‐Zn/ZnF2@Zn||MnO2 full cell displays an ultra‐long life span (79% capacity retention after 3000 cycles) and mechanical robustness (85% of the initial capacity for another 3000 cycles after bending 100 times). More importantly, the as‐assembled cells can easily power smart wearable devices to monitor the user's health condition. A composite polymer interface layer is artificially self‐assembled on the surface of the zinc anode; this in situ SEI shows favorable mechanical strength and electrochemical performance. The ZnF2 as a rigid layer efficiently inhibits dendrite growth, and the PAA serves as a flexible layer that releases the stresses during bending. The zinc anode exhibits excellent plating/stripping reversibility after protecting by this organic–inorganic SEI.

Non-flow aqueous zinc-bromine batteries without auxiliary components (e.g., pumps, pipes, storage tanks) and ion-selective membranes represent a cost-effective and promising technology for large-scale energy storage. Unfortunately, they generally suffer from serious diffusion and shuttle of polybromide (Br-, Br-3) due to the weak physical adsorption between soluble polybromide and host carbon materials, which results in low energy efficiency and poor cycling stability. Here, we develop a novel self-capture organic bromine material (1,1′-bis [3-(trimethylammonio)propyl]-4,4′-bipyridinium bromine, NVBr4) to successfully realize reversible solid complexation of bromide components for stable non-flow zinc-bromine battery applications. The quaternary ammonium groups (NV4+ ions) can effectively capture the soluble polybromide species based on strong chemical interaction and realize reversible solid complexation confined within the porous electrodes, which transforms the conventional \"liquid-liquid\" conversion of soluble bromide components into \"liquid-solid\" model and effectively suppresses the shuttle effect. Thereby, the developed non-flow zinc-bromide battery provides an outstanding voltage platform at 1.7 V with a notable specific capacity of 325 mAh g-1NvBr4 (1 A g-1), excellent rate capability (200 mAh g-1NvBr4 at 20 A g-1), outstanding energy density of 469.6 Wh kg-1 and super-stable cycle life (20,000 cycles with 100% Coulombic efficiency), which outperforms most of reported zinc-halogen batteries. Further mechanism analysis and DFT calculations demonstrate that the chemical interaction of quaternary ammonium groups and bromide species is the main reason for suppressing the shuttle effect. The developed strategy can be extended to other halogen batteries to obtain stable charge storage.

Outside front cover image: The bare zinc anode usually suffers from damnable dendrite growth and rampant side‐reaction on the surface, greatly impeding practical applications in flexible aqueous zinc batteries. Herein, a composite polymer interface layer is artificially self‐assembled on the surface of the zinc anode by graft‐modified fluorinated monomer, on which an organic‐inorganic hybrid solid electrolyte interface (SEI) with excellent ionic conductivity is formed by interacting with Zn2+. After the protection of the organic‐inorganic SEI, the battery shows excellent electrochemical performance. (https://doi.org/10.1002/smm2.1212)

Wastewater containing oil and polyacylamide is a kind of organic wastewater, which is hard to treat. The combined process of moving-bed biofilm reactor and sulphate-reducing bacteria was used to treat the wastewater. Operating conditions of moving-bed biofilm reactor and sulphate-reducing bacteria were studied. Results indicate that the oil removal efficiency by moving-bed biofilm reactor can reach above 90% with 9 hours hydraulic retention time at 25°C, but it has no effect on polyacylamide. Sulphate-reducing bacteria can degrade polyacylamide, and polyacylamide conversion is about 50% at 37°C with 4 days culture time and 9ml inoculation size. The effluent quality of wastewater containing oil and polyacylamide can meet requirements of the first level in integrated wastewater discharge standard.